Papers
1
Total Citations
1
H-Index
1
About
Dr. Sijing Li is a pathologist and researcher specializing in gynecologic oncology and rare soft tissue sarcomas, with a particular focus on uterine embryonal rhabdomyosarcoma (RMS)—an exceptionally rare and aggressive malignancy in adults. Her most cited work, a 2025 case report, illuminates the formidable diagnostic challenges of adult uterine RMS, a disease typically seen in children. By meticulously documenting the clinical, histologic, and immunohistochemical features of this case, Dr. Li provides a critical roadmap for pathologists and oncologists navigating this diagnostic minefield. Her contribution is especially valuable because adult RMS is often misdiagnosed as more common uterine sarcomas, leading to inappropriate treatment. While her citation count is modest, reflecting the niche nature of her work, its clinical significance is profound—it directly addresses a gap in the literature where management guidelines are virtually nonexistent. Dr. Li’s research underscores the importance of molecular diagnostics and multidisciplinary collaboration in rare tumors, and her case report serves as a foundational reference for future studies aimed at improving survival in this devastating disease. Her work exemplifies how single-case analyses can drive meaningful clinical awareness and change.
Research Focus
Key Achievements
Top Papers
- 1